Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Lung units which participate in gas exchange are known as 'recruited' lung. Patients with lung injury suffer from a proportion of units which do not participate in gas exchange (i.e. the derecruited state), which results in impaired gas exchange and induces an inflammatory cascade. Currently, there is no clinical practice guideline in our intensive care unit regarding lung recruitment strategies for children with lung injury. While many studies have demonstrated efficacy (ability to open the lung) and safety of recruitment maneuvers in adults, no such studies have been performed in children.
The primary purpose of this study is therefore to demonstrate the safety and efficacy of a recruitment protocol designed to maximally recruit collapsed lung in children with acute lung injury. Each study patient will follow a recruitment protocol (see Appendix 2). Two 'controls' will be utilized in this study: baseline ventilation (no recruitment maneuver) and the open lung approach (a sustained inflation followed by increased PEEP). Efficacy will be defined as an improvement in lung volume (as measured by nitrogen washout and electrical impedance tomography), and by an improvement in measured arterial partial pressure of oxygen. Safety will be defined as the incidence of barotrauma and hemodynamic consequences which occur during the protocol.
A secondary purpose of this study will be to further validate electrical impedance tomography (EIT) as a non-invasive tool describing the lung parenchyma by comparing it to an accepted standard method of measuring lung volumes, the multiple breath nitrogen washout technique. Validation of EIT would allow clinicians to have a non-invasive image of a patient's lungs without the risks imposed by radiography.
The information we learn will be instrumental in defining an optimal strategy for lung recruitment in children with lung injury.
| Condition | Intervention |
|---|---|
|
Acute Respiratory Distress Syndrome Acute Lung Injury |
Procedure: Recruitment maneuver |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury |
- PaO2 + PaCO2 of 400 or higher. [ Time Frame: 2 hours ] [ Designated as safety issue: No ]
- Safety - airleak or cardiac compromise. [ Time Frame: 4 hours ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 20 |
| Study Start Date: | November 2008 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Recruitment
Patients with hypoxic respiratory failure
|
Procedure: Recruitment maneuver
Three types of maneuvers will be performed.
Other Names:
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 1 Month to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
All intubated and mechanically ventilated patients on the Medical-Surgical Intensive Care Unit will be screened for the following inclusion criteria:
- Age: 44 weeks post conceptual age to 18 years
Acute Lung Injury (ALI): American European Consensus Committee definition of ALI40
- PaO2/FiO2<300 on ABG within past 6 hours,
- Acute onset of bilateral infiltrates on chest radiograph, and
- No evidence of left atrial hypertension
- Sedation: Must be receiving neuromuscular blockade or demonstrating apnea due to sedation
- Arterial line must be present
- Conventional mechanical ventilation
- Current PEEP levels between 5 and 15 cm H2O
Exclusion Criteria:
- Meets the above criteria for ALI for > 72 hours
- Active hemodynamic instability
- Prematurity (birth at post-conceptual age <37 weeks)
- Clinically recognized airways disease (including viral bronchiolitis)
- Uncuffed endotracheal tube in place
- Congenital heart disease
- Hemodynamically significant heart disease
- Congenital diaphragmatic hernia
- Recent (past 2 months) history of intrathoracic instrumentation (e.g., orthopedic instrumentation, cardiac pacemaker, thoracostomy)
- Pulmonary fibrosis
- Restrictive lung disease (other than acute lung injury/ARDS)
- Cystic fibrosis
- Severe pulmonary hypertension
- Severe brain injury with no intracranial pressure monitor or external ventricular drain in place
- Extra-corporeal life support
Contacts and Locations| Contact: Brian K Walsh, BS, MBA | 617-935-7885 | brian.walsh@childrens.harvard.edu |
| United States, Massachusetts | |
| Children's Hospital Boston | Recruiting |
| Boston, Massachusetts, United States, 02115 | |
| Contact: Brian K Walsh, BS, MBA, RRT 617-935-7885 brian.walsh@childrens.harvard.edu | |
| Principal Investigator: John H Arnold, MD | |
| Sub-Investigator: Gerhard Wolf, MD | |
| Sub-Investigator: John Kheir, MD | |
| Sub-Investigator: John Thompson, RRT-NPS | |
More Information
No publications provided
| Responsible Party: | John Arnold, MD Associated Professor, Children's Hospital Boston, Harvard Medical School |
| ClinicalTrials.gov Identifier: | NCT00830284 History of Changes |
| Other Study ID Numbers: | 08-07-0328, Recruitment |
| Study First Received: | December 24, 2008 |
| Last Updated: | August 3, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Hospital Boston:
|
Pediatric Acute Respiratory Distress Syndrome (ARDS) Pediatric Acute Lung Injury (ALI) |
Additional relevant MeSH terms:
|
Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Acute Lung Injury Lung Injury Lung Diseases Respiratory Tract Diseases |
Respiration Disorders Infant, Premature, Diseases Infant, Newborn, Diseases Thoracic Injuries Wounds and Injuries |
ClinicalTrials.gov processed this record on June 18, 2013